blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3570864

EP3570864 - PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  25.10.2019
Database last updated on 18.11.2024
FormerThe international publication has been made
Status updated on  28.07.2018
Most recent event   Tooltip15.12.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
Protagonist Therapeutics, Inc.
7707 Gateway Boulevard
Suite 140
Newark, California 94560 / US
[2019/48]
Inventor(s)01 / BHANDARI, Ashok
2629 Lotus Street
Pleasanton California 94588 / US
02 / BOURNE, Gregory
19 Greenwood Close
Moggill Queensland 4070 / AU
 [2019/48]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2019/48]Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Ganghoferstraße 68 B
80339 München / DE
Application number, filing date18741939.518.01.2018
[2019/48]
WO2018US14257
Priority number, dateUS201762447778P18.01.2017         Original published format: US 201762447778 P
[2019/48]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018136646
Date:26.07.2018
Language:EN
[2018/30]
Type: A1 Application with search report 
No.:EP3570864
Date:27.11.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 26.07.2018 takes the place of the publication of the European patent application.
[2019/48]
Search report(s)International search report - published on:US26.07.2018
(Supplementary) European search report - dispatched on:EP27.11.2020
ClassificationIPC:A61K38/00, A61P1/00, C07K7/02, C07K7/08, C07K7/50, C07K7/64, C07K14/54, C07K14/715
[2020/39]
CPC:
A61P1/00 (EP); C07K14/4703 (US); C07K14/7155 (EP);
C07K7/08 (EP,US); C07K7/64 (US); A61K38/00 (EP,US)
Former IPC [2019/48]A61K38/00, A61P1/00, C07K7/02, C07K7/08, C07K7/50, C07K7/64, C07K14/54
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/48]
TitleGerman:PEPTIDINHIBITOREN DES INTERLEUKIN-23-REZEPTORS UND DEREN VERWENDUNG ZUR BEHANDLUNG ENTZÜNDLICHER ERKRANKUNGEN[2019/48]
English:PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES[2019/48]
French:PEPTIDES INHIBITEURS DU RÉCEPTEUR DE L'INTERLEUKINE-23 ET LEUR UTILISATION POUR TRAITER DES MALADIES INFLAMMATOIRES[2019/48]
Entry into regional phase16.08.2019National basic fee paid 
16.08.2019Search fee paid 
16.08.2019Designation fee(s) paid 
16.08.2019Examination fee paid 
Examination procedure16.08.2019Examination requested  [2019/48]
23.06.2021Amendment by applicant (claims and/or description)
Fees paidRenewal fee
14.01.2020Renewal fee patent year 03
13.01.2021Renewal fee patent year 04
16.12.2021Renewal fee patent year 05
24.01.2023Renewal fee patent year 06
14.12.2023Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]WO2016011208  (PROTAGONIST THERAPEUTICS INC [US], et al) [I] 1-15 * page 177 - page 219; tables 3-8 * * sequences 1-1029 * * page 196; sequence 645 *;
 [AP]WO2017011820  (PROTAGONIST THERAPEUTICS INC [US], et al) [AP] 1-15 * sequences 1-1256 * * tables E3A-E34 ** page 196; sequence 645 *;
 [A]  - CHRISTIANE QUINIOU ET AL, "Specific targeting of the IL-23 receptor, using a novel small peptide noncompetitive antagonist, decreases the inflammatory response", AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY , INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, US, (20141115), vol. 307, no. 10, doi:10.1152/ajpregu.00540.2013, ISSN 0363-6119, pages R1216 - R1230, XP055721662 [A] 1-15 * page 1217; figure 1 * * page 1219, column r, paragraph 5 - page 1220, column l, paragraph 1 *

DOI:   http://dx.doi.org/10.1152/ajpregu.00540.2013
 [A]  - MILAN KUCHAR ET AL, "Human interleukin-23 receptor antagonists derived from an albumin-binding domain scaffold inhibit IL-23-dependent ex vivo expansion of IL-17-producing T-cells", PROTEINS: STRUCTURE, FUNCTION, AND BIOINFORMATICS, (20131101), doi:10.1002/prot.24472, ISSN 0887-3585, pages n/a - n/a, XP055109904 [A] 1-15 * abstract * * page 2; figure 1 * * page 9; table 1 *

DOI:   http://dx.doi.org/10.1002/prot.24472
International search[A]US2003166138  (KINSELLA TODD [US], et al) [A] 1-2, 9/1-2, 10/9/1-2, 12-13 14/12-13 * ; claim 1 *;
 [A]WO2016011208  (PROTAGONIST THERAPEUTICS INC [US], et al) [A] 1-2, 9/1-2, 10/9/1-2, 12-13 14/12-13 * ; paragraphs [0010], [0011], [0013] *;
 [A]US2016039878  (GALLAGHER GRANT [US], et al) [A] 1-2, 9/1-2, 10/9/1-2, 12-13 14/12-13 * ; abstract *;
 [PY]WO2017011820  (PROTAGONIST THERAPEUTICS INC [US], et al) [PY] 1-2, 9/1-2, 10/9/1-2, 12-13 14/12-13* ; entire document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.